SCHEMBL821336

SCHEMBL821336

CC(O)C(=O)OC(C)C(=O)OCCOC(=O)C(C)OC(=O)C(C)O

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12939714 0.94 MEN1 (0.42) TP53MEN1KMT2A
SCHEMBL12939711 0.94 MEN1 (0.42) TP53MEN1KMT2A
SCHEMBL10025248 0.92 TSHR (0.36)
SCHEMBL16307596 0.92 MEN1 (0.41) TP53MEN1KMT2A
SCHEMBL16203062 0.91 ALDH1A1 (0.32) TP53MEN1KMT2A
SCHEMBL10000217 0.91 NAAA (0.33) TP53MEN1KMT2A
SCHEMBL16843060 0.90 ALDH1A1 (0.41) MEN1KMT2A
SCHEMBL16843063 0.89 ALDH1A1 (0.31) MEN1KMT2A
SCHEMBL16943384 0.89 NAAA (0.36)
SCHEMBL4731208 0.89 TSHR (0.34) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9334338-B2 Water-soluble degradable synthetic vinyl polymers and related methods HALLIBURTON ENERGY SERVICES, INC. (US) 2016-05-10 US disclosed
US-8772205-B2 Water-soluble degradable synthetic vinyl polymers and related methods HALLIBURTON ENERGY SERVICES, INC. (US) 2014-07-08 US disclosed
US-8496971-B2 Treatment of osteoporosis UNIVERSITAET ROSTOCK (DE) 2013-07-30 US disclosed
US-20110269651-A1 Water-Soluble Degradable Synthetic Vinyl Polymers and Related Methods HALLIBURTON ENERGY SERVICES, INC. 2011-11-03 US disclosed
US-20110269904-A1 Water-Soluble Degradable Synthetic Vinyl Polymers and Related Methods HALLIBURTON ENERGY SERVICES, INC. 2011-11-03 US disclosed
US-7884157-B2 addition-condensation copolymerization of polyethylene glycol and a polyvinyl alcohol, and of a lactone or dilactone monomer in presence of calcium hydride or magnesium hydride catalyst CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2011-02-08 US disclosed
US-20110027381-A1 TREATMENT OF OSTEOPOROSIS UNIVERSITAT ROSTOCK 2011-02-03 US disclosed
US-7795467-B1 Bioabsorbable, biobeneficial polyurethanes for use in medical devices ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) 2010-09-14 US disclosed
US-20080312376-A1 Process for Preparing Copolymers by Anionic Solvent-Free Polymerization CENTRE NATIONAL DE LA RECHERCH SCIENTIFIQUE (FR) 2008-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110027381-A1 TREATMENT OF OSTEOPOROSIS SOST, COL1A1, COL14A1 TP53 2433/4885MEN1 3149/4885KMT2A 3131/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.